Skip to main content

Array BioPharma Value Stock - Dividend - Research Selection

Array BioPharma

ISIN: US04269X1054, WKN: 580564

Market price date: 30.11.-0001
Market price: 0,00 USD

Array BioPharma Fundamental data and company key figures of the share

Annual reports in USD
Key figures 29-09-2018
Cash flow
Net operating cash flow 386.073.000
Capital Expenditures 0
Free cash flow 386.072.992
Balance sheet
Total Equity 305.151.000
Liabilities & Shareholders equity 923.581.000
Income statement
Net income 39.745.000
Eps (diluted) -0,740
Diluted shares outstanding 198.490.000
Net sales/revenue 647.899.000

Fundamental ratios calculated on: 30-11--0001

Key figures 30-11--0001
Cash flow
P/C 0,00
P/FC 0,00
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization9.497.746.432,00 USD
Raw Data Source
Stock Split

Description of the company

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company´s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,